By John Leavitt, Ph.D. Nerac Analyst
Originally Published: July 21, 2014
Over the past two decades I have been somewhat amused by the seemingly abrupt emergence of the fields called “genomics” and “proteomics” and all of the other “…omics”. The fanfare surrounding their emergence seems similar in effect to drinking too much espresso in the morning.
The earliest review on the subject of “proteomics” (with an “s”) that I could find was published in 1997 by James entitled “Protein identification in the post-genome era: the rapid rise of proteomics” in the Quarterly Review of Biophysics, a year when only a few papers mentioned this word. The word “proteome” was actually first trademarked by Jim Garrels at Proteome, Inc. in 1995. Simply put, “proteomics” now defines an industry that is focused on linking specific proteins to disease states for the purpose of improved diagnosis and treatment.
- 36New analyst brings extensive experience in engineering, energy and environmental systems Read the full release here.
- 30New analyst brings extensive experience in the biotechnology industry, primarily in the areas of chemical and biochemical defense systems, electrochemical devices, nanotechnology, materials chemistry and physical-organic chemistry Read the full release here.
- 30XcellR8 welcomes welcomes Roger LaFlamme, Co-founder and COO of Rapid Radiant Technologies Read the full release here.